Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$0.42 - $0.72 $15,090 - $25,868
-35,929 Reduced 45.1%
43,729 $27,000
Q3 2023

Nov 13, 2023

SELL
$0.6 - $1.53 $16,776 - $42,778
-27,960 Reduced 25.98%
79,658 $47,000
Q2 2023

Aug 14, 2023

BUY
$1.05 - $1.63 $9,804 - $15,220
9,338 Added 9.5%
107,618 $121,000
Q1 2023

May 12, 2023

BUY
$1.2 - $2.73 $28,364 - $64,529
23,637 Added 31.67%
98,280 $132,000
Q4 2022

Feb 13, 2023

BUY
$1.71 - $3.61 $41,595 - $87,813
24,325 Added 48.34%
74,643 $138,000
Q3 2022

Nov 14, 2022

SELL
$1.9 - $8.63 $93,603 - $425,156
-49,265 Reduced 49.47%
50,318 $124,000
Q2 2022

Aug 15, 2022

BUY
$2.13 - $9.01 $38,912 - $164,603
18,269 Added 22.47%
99,583 $243,000
Q1 2022

May 13, 2022

BUY
$6.28 - $15.59 $63,999 - $158,877
10,191 Added 14.33%
81,314 $648,000
Q4 2021

Feb 14, 2022

SELL
$14.7 - $28.67 $172,445 - $336,327
-11,731 Reduced 14.16%
71,123 $1.09 Million
Q3 2021

Nov 15, 2021

BUY
$24.31 - $33.6 $201,068 - $277,905
8,271 Added 11.09%
82,854 $2.36 Million
Q2 2021

Aug 13, 2021

BUY
$26.09 - $40.4 $72,399 - $112,110
2,775 Added 3.86%
74,583 $2.52 Million
Q1 2021

May 14, 2021

BUY
$33.06 - $56.93 $1.59 Million - $2.74 Million
48,106 Added 202.96%
71,808 $2.74 Million
Q4 2020

Feb 12, 2021

SELL
$39.09 - $57.4 $39,480 - $57,974
-1,010 Reduced 4.09%
23,702 $991,000
Q3 2020

Nov 16, 2020

SELL
$28.43 - $44.67 $168,874 - $265,339
-5,940 Reduced 19.38%
24,712 $1.07 Million
Q2 2020

Aug 14, 2020

BUY
$11.71 - $30.29 $50,388 - $130,337
4,303 Added 16.33%
30,652 $929,000
Q1 2020

May 14, 2020

BUY
$7.64 - $27.5 $62,212 - $223,932
8,143 Added 44.73%
26,349 $363,000
Q4 2019

Feb 13, 2020

BUY
$15.02 - $20.57 $81,378 - $111,448
5,418 Added 42.37%
18,206 $293,000
Q3 2019

Nov 13, 2019

BUY
$18.85 - $27.5 $241,053 - $351,670
12,788 New
12,788 $247,000
Q2 2019

Aug 14, 2019

SELL
$17.37 - $26.27 $528,916 - $799,921
-30,450 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$10.65 - $25.75 $324,292 - $784,087
30,450 New
30,450 $716,000

Others Institutions Holding NVTA

About Invitae Corp


  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.